KUALA LUMPUR: Maker of animal and human health products, Sunzen Biotech Bhd, is focusing on expanding its traditional Chinese medicine (TCM) business partly by making it more adaptable to the younger segment as it strives for a slice of the RM32bil market.
It also plans to expand the business through leveraging on the boom of the digital marketing platforms during the movement control order (MCO) which began on March 18.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!